Keyword Analysis & Research: cd37

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
cd370.370.72146984

Keyword Research: People who searched cd37 also searched

Keyword CPC PCC Volume Score
cd370.990.7431514
cd3710.430.9356774
cd3771.640.2399132
cd3700.810.2608817
cd37tir1.880.5413257
cd377 dmrb1.350.3427495
cd3721.980.8998564
cd37 b cell1.620.971651
cd37 v31.70.4852149
cd37 gene1.210.8887119
cd3710a10.650.8273130
cd371 aml1.190.7988974
cd371 gene0.940.1262395

Search Results related to cd37 on Search Engine

  • CD37 - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/CD37

    WebCD37 is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. Alternate splicing results in multiple transcript variants encoding different isoforms. CD37 controls both humoral and cellular immune responses.

    DA: 76 PA: 42 MOZ Rank: 43

  • CD37 Gene - GeneCards | CD37 Protein | CD37 Antibody

    genecards.org

    https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD37

    WebApr 2, 2024 · CD37 (CD37 Molecule) is a Protein Coding gene. Diseases associated with CD37 include Osteogenesis Imperfecta, Type Iii and Mantle Cell Lymphoma. Among its related pathways are TYROBP causal network in microglia. An important paralog of this gene is CD82.

    DA: 3 PA: 27 MOZ Rank: 88

  • CD37 in B Cell Derived Tumors—More than Just a Docking Point for

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765243/

    WebDec 15, 2020 · CD37 is a tetraspanin expressed prominently on the surface of B cells. It is an attractive molecular target exploited in the immunotherapy of B cell-derived lymphomas and leukemia. Currently, several monoclonal antibodies targeting CD37 as well as chimeric antigen receptor-based immunotherapies are being developed and investigated in clinical ...

    DA: 4 PA: 4 MOZ Rank: 93

  • CD37 high expression as a potential biomarker and association ... - PubMed

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/32400873/

    WebMay 29, 2020 · Abstract. Background: CD37, a member of the transmembrane 4 superfamilies (TM4SF), has been proved to be abnormally expressed in a range of malignancies. Herein, we investigate the effects of CD37 expression and analyze its clinical outcome in acute myeloid leukemia (AML) patients.

    DA: 50 PA: 10 MOZ Rank: 58

  • DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with ... - Nature

    nature.com

    https://www.nature.com/articles/s41408-020-0292-7

    WebApr 28, 2020 · DuoHexaBody-CD37, a bispecific CD37 antibody with the E430G hexamerization-enhancing mutation targeting two non-overlapping epitopes on CD37 (biparatopic), demonstrated potent and superior...

    DA: 1 PA: 40 MOZ Rank: 3

  • CD37 protein expression summary - The Human Protein Atlas

    proteinatlas.org

    https://www.proteinatlas.org/ENSG00000104894-CD37

    WebPROTEIN SUMMARY SECTION OVERVIEW GENE INFORMATION RNA DATA ANTIBODY DATA. CD37 (TSPAN26) protein expression summary.

    DA: 4 PA: 77 MOZ Rank: 85

  • The clinical features, prognostic significance, and immune

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564053/

    WebNov 11, 2021 · Clinically, CD37 represents a promising target for B- and T-cell lymphoma therapy and has recently been validated as a druggable target, with anti-CD37 monoclonal antibodies and antibody-drug conjugates being used in clinical trials of both B- and T-cell lymphoma (Pagel et al., 2015). These findings indicate that CD37 is involved in regulating ...

    DA: 71 PA: 96 MOZ Rank: 62

  • Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956426/

    WebFeb 26, 2021 · A novel mouse monoclonal anti-human CD37 antibody (clone 2B8D12F2D4) was generated with high binding affinity for CD37 antigen (KD = 1.6 nM). The CD37 antibody specifically recognized cell surface CD37 protein in lymphoma cells and not in multiple myeloma or other types of cancer.

    DA: 13 PA: 57 MOZ Rank: 19

  • Phase 1 first-in-human trial of the anti-CD37 antibody BI ... - Nature

    nature.com

    https://www.nature.com/articles/s41375-019-0475-z

    WebMay 14, 2019 · Upon cross-ligation, CD37 can function as a cell death receptor in CLL cells [ 3 ]. Thus, CD37 is an attractive target for CLL. BI 836826 is a chimeric mouse–human monoclonal antibody that...

    DA: 52 PA: 19 MOZ Rank: 43

  • Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or

    ashpublications.org

    https://ashpublications.org/blood/article/138/Supplement%201/653/479975/Phase-1-Study-of-CD37-Directed-CAR-T-Cells-in

    WebNov 5, 2021 · Abstract. Background: CD37 is a tetraspanin molecule expressed in B-cell and some T-cell lymphomas. We designed a Chimeric Antigen Receptor (CAR) targeting CD37 and with 4-1BB and CD3z intracellular signaling domains (CART37).

    DA: 47 PA: 88 MOZ Rank: 83